MICROORGANISM COMPRISING GENETIC MODIFICATION THAT INCREASES ACTIVITY OF MULTIDRUG TRANSPORTER, AND METHOD FOR PRODUCING TRYPTOPHAN METABOLITES BY USING SAME

Disclosed is a recombinant microorganism comprising a genetic modification that increases the activity of a multidrug transporter A (multidrug efflux system subunit A: MdtA). A recombinant microorganism comprising genetic modification that increases the activity of a multidrug transporter and a meth...

Full description

Saved in:
Bibliographic Details
Main Authors RYU, Gyu Ri, JEON, Ae Ji, BAE, Hyun Ae, JANG, Jae Woo
Format Patent
LanguageEnglish
French
Korean
Published 24.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a recombinant microorganism comprising a genetic modification that increases the activity of a multidrug transporter A (multidrug efflux system subunit A: MdtA). A recombinant microorganism comprising genetic modification that increases the activity of a multidrug transporter and a method for producing tryptophan metabolites by using same enable mass-production of tryptophan metabolites. L'invention concerne un micro-organisme recombinant comprenant une modification génétique qui augmente l'activité d'un transporteur de médicaments multiples A (sous-unité A de système d'efflux de médicaments multiples : MdtA). Un micro-organisme recombinant comprenant une modification génétique qui augmente l'activité d'un transporteur de médicaments multiples et un procédé de production de métabolites de tryptophane à l'aide de celui-ci permettent la production en masse de métabolites de tryptophane. 다중약물 수송체 A(Multidrug efflux system subunit A: MdtA)의 활성을 증가시키는 유전적 변형(genetic modification)을 포함하는 재조합 미생물에 관한 것이다. 다중약물 수송체의 활성을 증가시키는 유전적 변형을 포함하는 재조합 미생물, 및 그를 이용한 트립토판 대사체를 생산하는 방법은 트립토판 대사체의 대량 생산을 가능하게 할 수 있다.
Bibliography:Application Number: WO2020KR11315